{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:41:57Z","timestamp":1740145317094,"version":"3.37.3"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-023-01263-5","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T03:28:01Z","timestamp":1686799681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["First Ecuadorian statement consensus for the evaluation and treatment of osteoporosis"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0221-8276","authenticated-orcid":false,"given":"Carlos","family":"Rios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3978-0799","authenticated-orcid":false,"given":"Genessis","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Vera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Zu\u00f1iga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Jervis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Guevara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frankl\u00edn","family":"Ugu\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4052-8681","authenticated-orcid":false,"given":"Osvaldo Daniel","family":"Messina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4345-7089","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Neyro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8678-2845","authenticated-orcid":false,"given":"Roberto","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,15]]},"reference":[{"issue":"2","key":"1263_CR1","first-page":"372","volume":"30","author":"OS Betancourt","year":"2014","unstructured":"Betancourt OS (2014) Densidad mineral \u00d3sea, calcio diet\u00e9tico y factores presuntivos de riesgo de osteoporosis en mujeres ecuatorianas de la tercera edad. Nutr Hosp 30(2):372\u2013384","journal-title":"Nutr Hosp"},{"key":"1263_CR2","unstructured":"Linstone HA, Turoff M (1975) The delphi method. Addison-Wesley Reading, MA"},{"issue":"2","key":"1263_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.semarthrit.2010.12.001","volume":"41","author":"R Nair","year":"2011","unstructured":"Nair R, Aggarwal R, Khanna D (2011) Methods of formal consensus in classification\/diagnostic criteria and guideline development. Semin Arthritis Rheum 41(2):95\u2013105","journal-title":"Semin Arthritis Rheum"},{"key":"1263_CR4","first-page":"138","volume-title":"Group Process and Productivity","author":"S Jackson","year":"1992","unstructured":"Jackson S (1992) Team composition in organizational settings: issues in managing an increasingly diverse work force. In: Worchel S, Wood W, Simpson J (eds) Group Process and Productivity. UK, Sage, London, pp 138\u2013173"},{"issue":"9","key":"1263_CR5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2105\/AJPH.74.9.979","volume":"74","author":"A Fink","year":"1984","unstructured":"Fink A, Kosecoff J, Chassin M, Brook RH (1984) Consensus methods: characteristics and guidelines for use. Am J Public Health 74(9):979\u2013983","journal-title":"Am J Public Health"},{"key":"1263_CR6","doi-asserted-by":"crossref","unstructured":"Dalkey NC (2018) Delphi. Routledge","DOI":"10.4324\/9781351106450-3"},{"key":"1263_CR7","volume-title":"Group techniques for program planning: a guide to nominal group and Delphi processes","author":"AL Delbecq","year":"1975","unstructured":"Delbecq AL, Van de Ven AH, Gustafson DH (1975) Group techniques for program planning: a guide to nominal group and Delphi processes. Scott, Foresman"},{"issue":"1","key":"1263_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41073-022-00122-0","volume":"7","author":"WT Gattrell","year":"2022","unstructured":"Gattrell WT, Hungin AP, Price A, Winchester CC, Tovey D, Hughes EL et al (2022) ACCORD guideline for reporting consensus-based methods in biomedical research and clinical practice: a study protocol. Res Integr Peer Rev 7(1):1\u201310","journal-title":"Res Integr Peer Rev"},{"key":"1263_CR9","doi-asserted-by":"crossref","unstructured":"Moher D, Schulz KF, Simera I, Altman DG (2010) Guidance for developers of health research reporting guidelines. PLoS Med. 7(2)","DOI":"10.1371\/journal.pmed.1000217"},{"key":"1263_CR10","unstructured":"GRADE Working Group (2013) GRADE handbook for grading quality of evidence and strength of recommendations [Internet]. Sch\u00fcnemann H, Bro\u017cek J, Guyatt G, Oxman A, editors. 2013. Available from: guidelinedevelopment.org\/handbook"},{"issue":"10","key":"1263_CR11","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S et al (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25(10):2359\u20132381","journal-title":"Osteoporos Int"},{"key":"1263_CR12","unstructured":"Ministerio de Salud P\u00fablica del Ecuador (2017) Registro Estad\u00edstico Camas y Egresos Hospitalarios 2017 [Internet]. Quito, Ecuador; 2017. Available from: https:\/\/www.ecuadorencifras.gob.ec\/documentos\/web-inec\/Estadisticas_Sociales\/Camas_Egresos_Hospitalarios\/Cam_Egre_Hos_2017\/Presentacion_CEH_2017.pdf.\u00a0Accessed October 2021"},{"issue":"2","key":"1263_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4321\/S1889-836X2018000200002","volume":"10","author":"E Lopez","year":"2018","unstructured":"Lopez E, Chedraui P, Franco KG, Blum DM, Riofr\u00edo JP, Baja\u00f1a AS (2018) Osteoporotic hip fractures in older adults in Ecuador 2016. Rev Osteoporos y Metab Miner 10(2):63\u201370","journal-title":"Rev Osteoporos y Metab Miner"},{"issue":"5","key":"1263_CR14","first-page":"438","volume":"25","author":"CH Orces","year":"2009","unstructured":"Orces CH (2009) Epidemiology of hip fractures in Ecuador. Pan Am J Public Heal 25(5):438\u2013442","journal-title":"Pan Am J Public Heal"},{"issue":"1","key":"1263_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3923\/ijom.2018.23.28","volume":"11","author":"E Lopez-Gavilanes","year":"2018","unstructured":"Lopez-Gavilanes E, Diaz-Curel M, Orces C, Navarro-Chavez M, Bautista-Litardo N, Hernandez-Bonilla M et al (2018) Trends in mortality rates due to osteoporotic hip fractures in Ecuador from 1997 to 2016. Int J Osteoporos Metab Disord 11(1):23\u201328","journal-title":"Int J Osteoporos Metab Disord"},{"key":"1263_CR16","doi-asserted-by":"crossref","unstructured":"Montala N, Juanola X, Collantes E, Mu\u00f1oz-Gomariz E, Gonzalez C, Gratacos J et al (2011) Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis. J Rheumatol [Internet]. 2011 May 1;38(5):893 LP \u2013 897. Available from: http:\/\/www.jrheum.org\/content\/38\/5\/893.abstract.\u00a0Accessed October 2021","DOI":"10.3899\/jrheum.100851"},{"key":"1263_CR17","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00198-015-3449-7","volume":"4","author":"X Wang","year":"2016","unstructured":"Wang X, Yan S, Liu C, Xu Y, Wan L, Wang Y et al (2016) Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis. Osteoporos Int 4:1413\u20131423","journal-title":"Osteoporos Int"},{"issue":"7","key":"1263_CR18","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/art.40818","volume":"71","author":"SK Tedeschi","year":"2019","unstructured":"Tedeschi SK, Kim SC, Guan H, Grossman JM, Costenbader KH (2019) Comparative fracture risks among United States Medicaid enrollees with and those without systemic lupus erythematosus. Arthritis Rheumatol (Hoboken, NJ) 71(7):1141\u20131146","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"6","key":"1263_CR19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Borgstrom F, De Laet C, Johansson H, Johnell O, Jonsson B et al (2005) Assessment of fracture risk. Osteoporos Int 16(6):581\u2013589","journal-title":"Osteoporos Int"},{"key":"1263_CR20","doi-asserted-by":"publisher","unstructured":"Lewiecki EM, Bilezikian JP, Kagan R, Krakow D, McClung MR, Miller PD, et al (2019) Proceedings of the 2019 Santa Fe Bone Symposium: new concepts in the care of osteoporosis and rare bone diseases. J Clin Densitom [Internet]. 2019; Available from: https:\/\/doi.org\/10.1016\/j.jocd.2019.09.006","DOI":"10.1016\/j.jocd.2019.09.006"},{"issue":"7","key":"1263_CR21","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/jbmr.2204","volume":"29","author":"SN Morin","year":"2014","unstructured":"Morin SN, Lix LM, Leslie WD (2014) The importance of previous fracture site on osteoporosis diagnosis and incident fractures in women. J Bone Miner Res 29(7):1675\u20131680","journal-title":"J Bone Miner Res"},{"issue":"5","key":"1263_CR22","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00198-014-2655-z","volume":"25","author":"ES Siris","year":"2014","unstructured":"Siris ES, Adler R, Bilezikian J, Bolognese M, Dawson-Hughes B, Favus MJ et al (2014) The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group. Osteoporos Int 25(5):1439\u20131443","journal-title":"Osteoporos Int"},{"issue":"11","key":"1263_CR23","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archinte.159.11.1215","volume":"159","author":"DM Kado","year":"1999","unstructured":"Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR (1999) Vertebral fractures and mortality in older women: a prospective study Study of Osteoporotic Fractures Research Group. Arch Intern Med. 159(11):1215\u201320","journal-title":"Arch Intern Med."},{"key":"1263_CR24","unstructured":"Robinson WA, Carlson BC, Poppendeck H, Wanderman NR, Bunta AD, Murphy S, et al (2019) Osteoporosis-related vertebral fragility fractures: a review and analysis of the American Orthopaedic Association\u2019s Own the Bone Database. Spine (Phila Pa 1976) [Internet]. 2019; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31770343.\u00a0Accessed October 2021"},{"key":"1263_CR25","doi-asserted-by":"publisher","unstructured":"Jia H, Lubetkin EI, DeMichele K, Stark DS, Zack MM, Thompson WW (2019) Prevalence, risk factors, and burden of disease for falls and balance or walking problems among older adults in the U.S. Prev Med (Baltim) [Internet]. 126(April):105737. Available from: https:\/\/doi.org\/10.1016\/j.ypmed.2019.05.025","DOI":"10.1016\/j.ypmed.2019.05.025"},{"key":"1263_CR26","unstructured":"Murray C, Lopez A. Global and regional descriptive epidemiology of disability: incidence, prevalence, health expectations and years lived with disability. Bostton; 1996."},{"key":"1263_CR27","doi-asserted-by":"crossref","unstructured":"Tinetti M, Speechley M, Ginter S (1988) Risk factors for falls among elderly persons living in the community. N Eng J Med. 1701\u20137","DOI":"10.1056\/NEJM198812293192604"},{"key":"1263_CR28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/ageing\/17.6.365","volume":"17","author":"A Blake","year":"1988","unstructured":"Blake A, Morgan K, Bendall M, Dallosso H, Ebrahim S, Arie T et al (1988) Falls by elderly people at home: prevalence and associated factors. Age Ageing 17:365\u2013372","journal-title":"Age Ageing"},{"key":"1263_CR29","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0895-4356(01)00349-3","volume":"54","author":"A Tromp","year":"2001","unstructured":"Tromp A, Pluijm S, Smitt J (2001) Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol 54:833\u2013844","journal-title":"J Clin Epidemiol"},{"key":"1263_CR30","doi-asserted-by":"publisher","unstructured":"Shuhart CR, Yeap SS, Anderson PA, Jankowski LG, Lewiecki EM, Morse LR, et al (2019) Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, periprosthetic and orthopedic bone health, transgender medicine, and pediatrics. J Clin Densitom [Internet]. 22(4):453\u201371. Available from: https:\/\/doi.org\/10.1016\/j.jocd.2019.07.001","DOI":"10.1016\/j.jocd.2019.07.001"},{"key":"1263_CR31","unstructured":"Kanis J, on behalf of the World Health Organization Scientific Group (2007) Assessment of osteoporosis at the primary healthcare level. Technical Report. WHO Collaborating Centre. Sheffield: University of Sheffield"},{"issue":"1 SUPPL.","key":"1263_CR32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40520-013-0074-1","volume":"25","author":"M Celi","year":"2013","unstructured":"Celi M, Rao C, Scialdoni A, Tempesta V, Gasbarra E, Pistillo P et al (2013) Bone mineral density evaluation in osteoporosis: why yes and why not? Aging Clin Exp Res 25(1 SUPPL.):47\u201349","journal-title":"Aging Clin Exp Res"},{"key":"1263_CR33","doi-asserted-by":"crossref","unstructured":"Andreoli A, Bazzocchi A, Celi M, Lauro D, Sorge R, Tarantino U, et al (2011) Relationship between body composition, body mass index and bone mineral density in a large population of normal, osteopenic and osteoporotic women. Radiol Med [Internet]. 2011\/06\/04. 116(7):1115\u201323. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21643640.\u00a0Accessed October 2021","DOI":"10.1007\/s11547-011-0689-2"},{"key":"1263_CR34","doi-asserted-by":"crossref","unstructured":"Hamdy RC, Petak SM, Lenchik L, Committee IS for CDPDP and SA (2002) Which central dual X-ray absorptiometry skeletal sites and regions of interest should be used to determine the diagnosis of osteoporosis? J Clin Densitom [Internet]. 5 Suppl:S11\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/12464707.\u00a0Accessed October 2021","DOI":"10.1385\/JCD:5:3S:S11"},{"issue":"7","key":"1263_CR35","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00198-005-1880-x","volume":"16","author":"L Ferrar","year":"2005","unstructured":"Ferrar L, Jiang G, Adams J, Eastell R (2005) Identification of vertebral fractures: an update. Osteoporos Int 16(7):717\u2013728","journal-title":"Osteoporos Int"},{"issue":"11","key":"1263_CR36","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1210\/jc.2006-1178","volume":"91","author":"EM Lewiecki","year":"2006","unstructured":"Lewiecki EM, Laster AJ (2006) Clinical review: Clinical applications of vertebral fracture assessment by dual-energy x-ray absorptiometry. J Clin Endocrinol Metab 91(11):4215\u20134222","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1263_CR37","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00198-005-2010-5","volume":"17","author":"JT Schousboe","year":"2006","unstructured":"Schousboe JT, Debold CR (2006) Reliability and accuracy of vertebral fracture assessment with densitometry compared to radiography in clinical practice. Osteoporos Int 17(2):281\u2013289","journal-title":"Osteoporos Int"},{"key":"1263_CR38","doi-asserted-by":"crossref","unstructured":"Ross PD (1997) Clinical consequences of vertebral fractures. Am J Med. 1Aug;103(2A):30S-42S; discussion 42S-43S","DOI":"10.1016\/S0002-9343(97)90025-5"},{"issue":"3","key":"1263_CR39","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s001980050218","volume":"10","author":"LJ Melton 3rd","year":"1999","unstructured":"Melton LJ 3rd, Atkinson EJ, Cooper C, O\u2019Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporos Int 10(3):214\u2013221","journal-title":"Osteoporos Int"},{"key":"1263_CR40","doi-asserted-by":"publisher","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, et al (2020) American association of clinical endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract [Internet]. 26(s1):1\u201346. Available from: https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL","DOI":"10.4158\/GL-2020-0524SUPPL"},{"key":"1263_CR41","doi-asserted-by":"crossref","unstructured":"Kaptoge S, Armbrecht G, Felsenberg D, Lunt M, O\u2019Neill TW, Silman AJ, et al (2004) When should the doctor order a spine X-ray? Identifying vertebral fractures for osteoporosis care: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res [Internet]. 2004\/09\/07. 19(12):1982\u201393. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15537441.\u00a0Accessed October 2021","DOI":"10.1359\/jbmr.040901"},{"issue":"2","key":"1263_CR42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.crad.2003.07.005","volume":"59","author":"M Uetani","year":"2004","unstructured":"Uetani M, Hashmi R, Hayashi K (2004) Malignant and benign compression fractures: differentiation and diagnostic pitfalls on MRI. Clin Radiol 59(2):124\u2013131","journal-title":"Clin Radiol"},{"issue":"3","key":"1263_CR43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.rcl.2010.02.012","volume":"48","author":"JF Griffith","year":"2010","unstructured":"Griffith JF, Guglielmi G (2010) Vertebral fracture. Radiol Clin North Am 48(3):519\u2013529","journal-title":"Radiol Clin North Am"},{"issue":"Pt 2","key":"1263_CR44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/0004563213515190","volume":"51","author":"TT Hlaing","year":"2014","unstructured":"Hlaing TT, Compston JE (2014) Biochemical markers of bone turnover - uses and limitations. Ann Clin Biochem 51(Pt 2):189\u2013202","journal-title":"Ann Clin Biochem"},{"key":"1263_CR45","doi-asserted-by":"publisher","unstructured":"Guiducci L, Maffei S, Sabatino L, Zyw L, Battaglia D, Vannucci A, et al (2017) Significance of the ionized calcium measurement to assess calcium status in osteopenic\/osteoporosis postmenopausal outpatients. Gynecol Endocrinol [Internet]. 33(5):383\u20138. Available from: https:\/\/doi.org\/10.1080\/09513590.2016.1270932","DOI":"10.1080\/09513590.2016.1270932"},{"key":"1263_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/3831275","volume":"3831275","author":"G Maldonado","year":"2017","unstructured":"Maldonado G, Paredes C, Guerrero R, R\u00edos C (2017) Determination of Vitamin D status in a population of Ecuadorian subjects. Sci World J 3831275:1\u20136","journal-title":"Sci World J"},{"key":"1263_CR47","first-page":"8","volume":"545297","author":"CH Orces","year":"2015","unstructured":"Orces CH (2015) Vitamin D status among older adults residing in the Littoral and Andes mountains in Ecuador. Sci World J 545297:8","journal-title":"Sci World J"},{"key":"1263_CR48","doi-asserted-by":"publisher","unstructured":"Maldonado G, Guerrero R, R\u00edos C (2017) Prevalencia de vitamina D en pacientes con enfermedades autoinmunes en Ecuador: estudio restrospectivo. Rev Colomb Reumatol [Internet]. 24(4):205\u201310. Available from: https:\/\/doi.org\/10.1016\/j.rcreu.2017.08.001","DOI":"10.1016\/j.rcreu.2017.08.001"},{"key":"1263_CR49","doi-asserted-by":"crossref","unstructured":"Henriksen K, Leeming DJ, Christiansen C, Karsdal MA (2011) Use of bone turnover markers in clinical osteoporosis assessment in women: current issues and future options. Womens Health (Lond Engl) 7(6):689\u201398. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22040210.\u00a0Accessed October 2021","DOI":"10.2217\/WHE.11.74"},{"key":"1263_CR50","doi-asserted-by":"crossref","unstructured":"Leeming DJ, Alexandersen P, Karsdal MA, Qvist P, Schaller S, Tank\u00f3 LB (2006) An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice. Eur J Clin Pharmacol 62(10):781\u201392. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16912870.\u00a0Accessed October 2021","DOI":"10.1007\/s00228-006-0174-3"},{"key":"1263_CR51","doi-asserted-by":"crossref","unstructured":"Stumpf U, Hesse E, B\u00f6cker W, Kammerlander C, Neuerburg C, Schmidmaier R (2019) Differential diagnoses of osteoporosis TT - Differenzialdiagnosen der Osteoporose. Z Gerontol Geriatr 52(5):414\u201320. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31297588.\u00a0Accessed October 2021","DOI":"10.1007\/s00391-019-01571-x"},{"key":"1263_CR52","unstructured":"WHO Fracture Risk Assessment Tool (FRAX) (2020) [Internet]. [cited 2020 Jan 13]. Available from: http:\/\/www.shef.ac.uk\/FRAX.\u00a0Accessed October 2021"},{"key":"1263_CR53","doi-asserted-by":"publisher","unstructured":"Gavilanez EL, Johansson H, Mccloskey E, Harvey NC, Bajana AS, Blum DM et al (2019) Assessing the risk of osteoporotic fractures: the Ecuadorian FRAX model. Arch Osteoporos\u00a014(1):93. https:\/\/doi.org\/10.1007\/s11657-019-0644-8","DOI":"10.1007\/s11657-019-0644-8"},{"key":"1263_CR54","volume-title":"Assessment of osteoporosis at the primary healthcare level","author":"J Kanis","year":"2008","unstructured":"Kanis J (2008) Assessment of osteoporosis at the primary healthcare level. World Health Organization Collaborating Centre University of Sheffield. Sheffield, UK"},{"key":"1263_CR55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-019-05176-3","volume":"31","author":"JA Kanis","year":"2020","unstructured":"Kanis JA, Harvey NC, Mccloskey E, Bruyere O, Veronese N, Lorentzon M et al (2020) Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures. Osteoporos Int 31:1\u201312","journal-title":"Osteoporos Int"},{"issue":"4","key":"1263_CR56","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s40520-022-02100-4","volume":"34","author":"EM Curtis","year":"2022","unstructured":"Curtis EM, Reginster JY, Al-Daghri N, Biver E, Brandi ML, Cavalier E et al (2022) Management of patients at very high risk of osteoporotic fractures through sequential treatments. Aging Clin Exp Res 34(4):695\u2013714","journal-title":"Aging Clin Exp Res"},{"key":"1263_CR57","doi-asserted-by":"publisher","unstructured":"Maldonado G, Intriago M, Larroude M, Aguilar G, Moreno M, Gonzalez J et al (2020) Common errors in dual-energy X-ray absorptiometry scans in imaging centers in Ecuador. Arch Osteoporos\u00a015(1):6. https:\/\/doi.org\/10.1007\/s11657-019-0673-3","DOI":"10.1007\/s11657-019-0673-3"},{"key":"1263_CR58","doi-asserted-by":"crossref","unstructured":"Martineau P, Leslie WD (2018) The utility and limitations of using trabecular bone score with FRAX. Curr Opin Rheumatol [Internet]. 30(4):412\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29528866.\u00a0Accessed October 2021","DOI":"10.1097\/BOR.0000000000000504"},{"key":"1263_CR59","doi-asserted-by":"crossref","unstructured":"Compston J (2015) FRAX--Where are we now? Maturitas [Internet]. 2015\/07\/31. 82(3):284\u20137. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26277257.\u00a0Accessed October 2021","DOI":"10.1016\/j.maturitas.2015.07.024"},{"issue":"3","key":"1263_CR60","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/MCO.0000000000000162","volume":"18","author":"RR Deer","year":"2015","unstructured":"Deer RR, Volpi E (2015) Protein intake and muscle function in older adults. Curr Opin Clin Nutr Metab Care 18(3):248\u2013253","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"1263_CR61","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1359\/JBMR.040208","volume":"19","author":"HJ Wengreen","year":"2004","unstructured":"Wengreen HJ, Munger RG, West NA, Cutler DR, Corcoran CD, Zhang J et al (2004) Dietary protein intake and risk of osteoporotic hip fracture in elderly residents of Utah. J Bone Miner Res 19(4):537\u2013545","journal-title":"J Bone Miner Res"},{"key":"1263_CR62","doi-asserted-by":"crossref","unstructured":"Rizzoli R, Bonjour J-P (2004) Dietary protein and bone health. Vol. 19, Journal of bone and mineral research\u202f: the official journal of the American Society for Bone and Mineral Research. United States; p. 527\u201331.","DOI":"10.1359\/JBMR.040204"},{"issue":"2","key":"1263_CR63","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/gerona\/gls109","volume":"68","author":"AB Dufour","year":"2013","unstructured":"Dufour AB, Hannan MT, Murabito JM, Kiel DP, McLean RR (2013) Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: the Framingham study. J Gerontol - Ser A Biol Sci Med Sci 68(2):168\u2013174","journal-title":"J Gerontol - Ser A Biol Sci Med Sci"},{"issue":"1","key":"1263_CR64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4082\/kjfm.2013.34.1.43","volume":"34","author":"J Kim","year":"2013","unstructured":"Kim J, Kim B, Lee H, Choi H, Won C (2013) The relationship between prevalence of osteoporosis and proportion of daily protein intake. Korean J Fam Med 34(1):43\u201348","journal-title":"Korean J Fam Med"},{"issue":"10","key":"1263_CR65","doi-asserted-by":"crossref","first-page":"801","DOI":"10.7326\/0003-4819-128-10-199805150-00002","volume":"128","author":"MA Schurch","year":"1998","unstructured":"Schurch MA, Rizzoli R, Slosman D, Vadas L, Vergnaud P, Bonjour JP (1998) Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 128(10):801\u20139","journal-title":"Ann Intern Med."},{"issue":"2","key":"1263_CR66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/rej.2012.1397","volume":"16","author":"EL Cadore","year":"2013","unstructured":"Cadore EL, Rodr\u00edguez-Ma\u00f1as L, Sinclair A, Izquierdo M (2013) Effects of different exercise interventions on risk of falls, gait ability, and balance in physically frail older adults: a systematic review. Rejuvenation Res 16(2):105\u2013114","journal-title":"Rejuvenation Res"},{"key":"1263_CR67","doi-asserted-by":"crossref","unstructured":"Kemmler W, Teschler M, Goisser S, Bebenek M, Stengel S Von, Bollheimer LC, et al (2015) Prevalence of sarcopenia in Germany and the corresponding effect of osteoarthritis in females 70 years and older living in the community\u202f: results of the FORMoSA study. 1565\u201373","DOI":"10.2147\/CIA.S89585"},{"key":"1263_CR68","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/CIA.S187588","volume":"14","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chai Y, Pan X, Shen H, Wei X, Xie Y (2019) Tai chi for treating osteopenia and primary osteoporosis: a meta-analysis and trial sequential analysis. Clin Interv Aging 14:91\u2013104","journal-title":"Clin Interv Aging"},{"issue":"24","key":"1263_CR69","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.1007\/s00018-017-2585-y","volume":"74","author":"Z Luo","year":"2017","unstructured":"Luo Z, Liu Y, Liu Y, Chen H, Shi S, Liu Y (2017) Cellular and molecular mechanisms of alcohol-induced osteopenia. Cell Mol Life Sci 74(24):4443\u20134453","journal-title":"Cell Mol Life Sci"},{"key":"1263_CR70","doi-asserted-by":"crossref","unstructured":"Wyshak G (2000) Teenaged girls, carbonated beverage consumption, and bone fractures. Arch Pediatr Adolesc Med [Internet]. 154(6):610\u20133. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10850510. Accessed October 2021","DOI":"10.1001\/archpedi.154.6.610"},{"key":"1263_CR71","doi-asserted-by":"crossref","unstructured":"McGartland C, Robson PJ, Murray L, Cran G, Savage MJ, Watkins D, et al (2003) Carbonated soft drink consumption and bone mineral density in adolescence: the Northern Ireland Young Hearts project. J Bone Miner Res 18(9):1563\u20139. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12968664. Accessed October 2021","DOI":"10.1359\/jbmr.2003.18.9.1563"},{"key":"1263_CR72","doi-asserted-by":"crossref","unstructured":"Whiting SJ, Healey A, Psiuk S, Mirwald R, Kowalski K, Bailey DA (2001) Relationship between carbonated and other low nutrient dense beverages and bone mineral content of adolescents. Nutr Res 21(8):1107\u201315. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0271531701003244. Accessed October 2021","DOI":"10.1016\/S0271-5317(01)00324-4"},{"key":"1263_CR73","doi-asserted-by":"crossref","unstructured":"Fitzpatrick L, Heaney RP (2003) Got soda? J Bone Miner Res 18(9):1570\u20132. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12968665. Accessed October 2021","DOI":"10.1359\/jbmr.2003.18.9.1570"},{"key":"1263_CR74","unstructured":"S\u00e1mano R, Rodr\u00edguez Ventura AL, God\u00ednez Mart\u00ednez EY, Rivera B, Medina Flores M, S\u00e1nchez B, et al 2013 Association of consumption of carbonated beverages and decalcification in woman on reproductive and non-reproductive age of Mexico City TT - Asociaci\u00f3n del consumo de bebidas carbonatadas y descalcificaci\u00f3n en mujeres en edad reproductiva y no reproducti. Nutr Hosp 28(5):1750\u20136. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24160242. Accessed October 2021"},{"issue":"4","key":"1263_CR75","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/ajcn\/84.4.936","volume":"84","author":"KL Tucker","year":"2006","unstructured":"Tucker KL, Morita K, Qiao N, Hannan MT, Cupples LA, Kiel DP (2006) Colas, but not other carbonated beverages, are associated with low bone mineral density in older women: the Framingham osteoporosis study. Am J Clin Nutr 84(4):936\u2013942","journal-title":"Am J Clin Nutr"},{"key":"1263_CR76","unstructured":"Amato D, Maravilla A, Montoya C, Gaja O, Revilla C, Guerra R, et al (1998) Acute effects of soft drink intake on calcium and phosphate metabolism in immature and adult rats. Rev Invest Clin [Internet]. 50(3):185\u20139. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9763881. Accessed October 2021"},{"key":"1263_CR77","doi-asserted-by":"crossref","unstructured":"Heckman MA, Weil J, Gonzalez de Mejia E (2010) Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 75(3):R77\u201387","DOI":"10.1111\/j.1750-3841.2010.01561.x"},{"key":"1263_CR78","doi-asserted-by":"crossref","first-page":"j5024","DOI":"10.1136\/bmj.j5024","volume":"359","author":"R Poole","year":"2017","unstructured":"Poole R, Kennedy OJ, Roderick P, Fallowfield JA, Hayes PC, Parkes J (2017) Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes. BMJ 359:j5024","journal-title":"BMJ"},{"issue":"4","key":"1263_CR79","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/ajcn\/60.4.573","volume":"60","author":"SS Harris","year":"1994","unstructured":"Harris SS, Dawson-Hughes B (1994) Caffeine and bone loss in healthy postmenopausal women. Am J Clin Nutr 60(4):573\u2013578","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1263_CR80","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/ajcn\/74.5.694","volume":"74","author":"PB Rapuri","year":"2001","unstructured":"Rapuri PB, Gallagher JC, Kinyamu HK, Ryschon KL (2001) Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr 74(5):694\u2013700","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"1263_CR81","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","volume":"16","author":"JA Kanis","year":"2005","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, De Laet C, Eisman JA et al (2005) Smoking and fracture risk: a meta-analysis. Osteoporos Int 16(2):155\u2013162","journal-title":"Osteoporos Int"},{"key":"1263_CR82","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bone.2018.01.014","volume":"108","author":"EA Marques","year":"2018","unstructured":"Marques EA, Elbejjani M, Gudnason V, Sigurdsson G, Lang T, Sigurdsson S et al (2018) Cigarette smoking and hip volumetric bone mineral density and cortical volume loss in older adults: the AGES-Reykjavik study. Bone 108:186\u2013192","journal-title":"Bone"},{"issue":"2","key":"1263_CR83","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/add.12761","volume":"110","author":"O Rom","year":"2015","unstructured":"Rom O, Reznick AZ, Keidar Z, Karkabi K, Aizenbud D (2015) Smoking cessation-related weight gain\u2013beneficial effects on muscle mass, strength and bone health. Addiction 110(2):326\u2013335","journal-title":"Addiction"},{"issue":"1","key":"1263_CR84","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00198-015-3290-z","volume":"27","author":"MH Thorin","year":"2016","unstructured":"Thorin MH, Wihlborg A, Akesson K, Gerdhem P (2016) Smoking, smoking cessation, and fracture risk in elderly women followed for 10 years. Osteoporos Int 27(1):249\u2013255","journal-title":"Osteoporos Int"},{"key":"1263_CR85","doi-asserted-by":"publisher","unstructured":"Marinucci L, Balloni S, Fettucciari K, Bodo M, Talesa VN, Antognelli C (2018) Nicotine induces apoptosis in human osteoblasts via a novel mechanism driven by H 2 O 2 and entailing Glyoxalase 1-dependent MG-H1 accumulation leading to TG2-mediated NF-kB desensitization: Implication for smokers-related osteoporosis. Free Radic Biol Med 117(May 2017):6\u201317. Available from: https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.01.017","DOI":"10.1016\/j.freeradbiomed.2018.01.017"},{"issue":"5","key":"1263_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjopen-2015-010657","volume":"6","author":"VA Goodwin","year":"2016","unstructured":"Goodwin VA, Hall AJ, Rogers E, Bethel A (2016) Orthotics and taping in the management of vertebral fractures in people with osteoporosis: a systematic review. BMJ Open 6(5):1\u20137","journal-title":"BMJ Open"},{"issue":"1","key":"1263_CR87","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2014.4.FOCUS1477","volume":"37","author":"V Chang","year":"2014","unstructured":"Chang V, Holly LT (2014) Bracing for thoracolumbar fractures. Neurosurg Focus 37(1):E3","journal-title":"Neurosurg Focus"},{"issue":"10","key":"1263_CR88","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.3346\/jkms.2016.31.10.1641","volume":"31","author":"YZ Jin","year":"2016","unstructured":"Jin YZ, Lee JH (2016) Effect of brace to osteoporotic vertebral fracture: a meta-analysis. J Korean Med Sci 31(10):1641\u20131649","journal-title":"J Korean Med Sci"},{"issue":"1S","key":"1263_CR89","doi-asserted-by":"crossref","first-page":"102779","DOI":"10.1016\/j.otsr.2020.102779","volume":"107","author":"S Prost","year":"2021","unstructured":"Prost S, Pesenti S, Fuentes S, Tropiano P, Blondel B (2021) Treatment of osteoporotic vertebral fractures. Orthop Traumatol Surg Res 107(1S):102779","journal-title":"Orthop Traumatol Surg Res"},{"key":"1263_CR90","doi-asserted-by":"crossref","unstructured":"Watts NB, Adler RA, Bilezikian JP, Drake MT, Eastell R, Orwoll ES et al (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97(6):1802\u201322. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22675062. Accessed October 2021","DOI":"10.1210\/jc.2011-3045"},{"issue":"8","key":"1263_CR91","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3899\/jrheum.081207","volume":"36","author":"SA Stoch","year":"2009","unstructured":"Stoch SA, Saag KG, Greenwald M, Sebba AI, Cohen S, Verbruggen N et al (2009) Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial. J Rheumatol 36(8):1705\u20131714","journal-title":"J Rheumatol"},{"key":"1263_CR92","doi-asserted-by":"crossref","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D (2019) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab 104(5):1595\u2013622. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30907953. Accessed October 2021","DOI":"10.1210\/jc.2019-00221"},{"issue":"1","key":"1263_CR93","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","volume":"31","author":"R Adler","year":"2016","unstructured":"Adler R, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greespan SL, McKinney R Jr, DE Pignolo RJS (2016) Managing osteoporosis patients after long-term bisphosphonate treatment. J Bone Min Res 31(1):16\u201335","journal-title":"J Bone Min Res"},{"issue":"12","key":"1263_CR94","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1172\/JCI118722","volume":"97","author":"GA Rodan","year":"1996","unstructured":"Rodan GA, Fleisch HA (1996) Bisphosphonates: mechanisms of action. J Clin Invest 97(12):2692\u20132696","journal-title":"J Clin Invest"},{"key":"1263_CR95","doi-asserted-by":"crossref","unstructured":"Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD et al (1991) Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88(6):2095\u2013105","DOI":"10.1172\/JCI115539"},{"issue":"12","key":"1263_CR96","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.3899\/jrheum.080634","volume":"35","author":"S Yeap","year":"2008","unstructured":"Yeap S, Fauzi A, Kong N, Halim A, Soehardy Z, Rahimah I (2008) A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus. J Rheumatol 35(12):2344\u20132347","journal-title":"J Rheumatol"},{"key":"1263_CR97","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA et al (2007) Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356(18):1809\u201322. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17476007. Accessed October 2021"},{"issue":"6","key":"1263_CR98","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/jbmr.3110","volume":"32","author":"AD Anastasilakis","year":"2017","unstructured":"Anastasilakis AD, Polyzos SA, Makras P, Aubry-Rozier B, Kaouri S, Lamy O (2017) Clinical features of 24 patients with rebound-associated vertebral fractures after denosumab discontinuation: systematic review and additional cases. J Bone Miner Res 32(6):1291\u20131296","journal-title":"J Bone Miner Res"},{"issue":"16","key":"1263_CR99","doi-asserted-by":"crossref","first-page":"E485","DOI":"10.1503\/cmaj.180115","volume":"190","author":"C Symonds","year":"2018","unstructured":"Symonds C, Kline G (2018) Warning of an increased risk of vertebral fracture after stopping denosumab. CMAJ 190(16):E485\u2013E486","journal-title":"CMAJ"},{"issue":"6","key":"1263_CR100","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-2814","volume":"93","author":"HG Bone","year":"2008","unstructured":"Bone HG, Bolognese MA, Yuen CK, Kendler DL, Wang H, Liu Y et al (2008) Effects of denosumab on bone mineral density and bone turnover in postmenopausal women. J Clin Endocrinol Metab 93(6):2149\u20132157","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1263_CR101","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11914-015-0295-7","volume":"13","author":"AG Costa","year":"2015","unstructured":"Costa AG, Bilezikian JP (2015) How long to treat with denosumab. Curr Osteoporos Rep 13(6):415\u2013420","journal-title":"Curr Osteoporos Rep"},{"issue":"7","key":"1263_CR102","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1210\/jc.2017-02669","volume":"103","author":"DW Dempster","year":"2018","unstructured":"Dempster DW, Brown JP, Fahrleitner-Pammer A, Kendler D, Rizzo S, Valter I et al (2018) Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 103(7):2498\u20132509","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1263_CR103","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/jc.2016-3170","volume":"102","author":"O Lamy","year":"2017","unstructured":"Lamy O, Gonzalez-Rodriguez E, Stoll D, Hans D, Aubry-Rozier B (2017) Severe rebound-associated vertebral fractures after denosumab discontinuation: 9 clinical cases report. J Clin Endocrinol Metab 102(2):354\u2013358","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1263_CR104","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jbmr.3359","volume":"33","author":"S Cummins","year":"2018","unstructured":"Cummins S, Ferrari S, Eastell R, Gilchrist N, Beck Jensen J-E, McClung M et al (2018) Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension. J Bone Miner Res 33(2):188\u2013189","journal-title":"J Bone Miner Res"},{"key":"1263_CR105","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","volume":"105","author":"E Tsourdi","year":"2017","unstructured":"Tsourdi E, Langdahl B, Cohen-Solal M, Aubry-Rozier B, Eriksen EF, Gua\u00f1abens N et al (2017) Discontinuation of Denosumab therapy for osteoporosis: a systematic review and position statement by ECTS. Bone 105:11\u201317","journal-title":"Bone"},{"issue":"3","key":"1263_CR106","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1210\/clinem\/dgaa007","volume":"105","author":"BP Lukert","year":"2020","unstructured":"Lukert BP (2020) Which drug next? Sequential therapy for osteoporosis. J Clin Endocrinol Metab 105(3):879\u2013881","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1263_CR107","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00198-011-1780-1","volume":"23","author":"N Freemantle","year":"2012","unstructured":"Freemantle N, Satram-Hoang S, Tang ET, Kaur P, MacArios D, Siddhanti S et al (2012) Final results of the DAPS (denosumab adherence preference satisfaction) study: a 24-month, randomized, crossover comparison with alendronate in postmenopausal women. Osteoporos Int 23(1):317\u2013326","journal-title":"Osteoporos Int"},{"key":"1263_CR108","doi-asserted-by":"publisher","unstructured":"Anastasilakis AD, Polyzos SA, Yavropoulou MP, Makras P (2020) Combination and sequential treatment in women with postmenopausal osteoporosis. Expert Opin Pharmacother [Internet]. 21(4):477\u201390. Available from: https:\/\/doi.org\/10.1080\/14656566.2020.1717468","DOI":"10.1080\/14656566.2020.1717468"},{"issue":"7","key":"1263_CR109","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1210\/jc.2009-2509","volume":"95","author":"RJ Santen","year":"2010","unstructured":"Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD et al (2010) Postmenopausal hormone therapy: an endocrine society scientific statement. J Clin Endocrinol Metab 95(7):s1-66","journal-title":"J Clin Endocrinol Metab"},{"key":"1263_CR110","doi-asserted-by":"crossref","unstructured":"Shoback D, Rosen CJ, Black DM, Cheung AM, Murad MH, Eastell R (2020) Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society guideline update. J Clin Endocrinol Metab. 105(3)","DOI":"10.1210\/clinem\/dgaa048"},{"issue":"4","key":"1263_CR111","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1359\/jbmr.071206","volume":"23","author":"PD Miller","year":"2008","unstructured":"Miller PD, Chines AA, Christiansen C, Hoeck HC, Kendler DL, Lewiecki EM et al (2008) Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study. J Bone Miner Res 23(4):525\u2013535","journal-title":"J Bone Miner Res"},{"issue":"1","key":"1263_CR112","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00198-011-1691-1","volume":"23","author":"SL Silverman","year":"2012","unstructured":"Silverman SL, Chines AA, Kendler DL, Kung AWC, Teglbjaerg CS, Felsenberg D et al (2012) Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study. Osteoporos Int 23(1):351\u2013363","journal-title":"Osteoporos Int"},{"key":"1263_CR113","doi-asserted-by":"publisher","unstructured":"Gua\u00f1abens N, Moro-\u00c1lvarez MJ, Casado E, Blanch-Rubi\u00f3 J, G\u00f3mez-Alonso C, D\u00edaz-Guerra GM et al (2019) The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment. Endocrine [Internet]. 64(3):441\u201355. Available from: https:\/\/doi.org\/10.1007\/s12020-019-01919-8","DOI":"10.1007\/s12020-019-01919-8"},{"key":"1263_CR114","doi-asserted-by":"publisher","unstructured":"Writing Group for the Women\u2019s Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial. JAMA 288(3):321\u201333. Available from: https:\/\/doi.org\/10.1001\/jama.288.3.321","DOI":"10.1001\/jama.288.3.321"},{"key":"1263_CR115","first-page":"CD008536","volume":"10","author":"G Formoso","year":"2016","unstructured":"Formoso G, Perrone E, Maltoni S, Balduzzi S, Wilkinson J, Basevi V et al (2016) Short-term and long-term effects of tibolone in postmenopausal women. Cochrane database Syst Rev. 10:CD008536","journal-title":"Cochrane database Syst Rev."},{"issue":"1","key":"1263_CR116","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jcem.87.1.8141","volume":"87","author":"K Modelska","year":"2002","unstructured":"Modelska K, Cummings S (2002) Tibolone for postmenopausal women: systematic review of randomized trials. J Clin Endocrinol Metab 87(1):16\u201323","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1263_CR117","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","volume":"359","author":"SR Cummings","year":"2008","unstructured":"Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P et al (2008) The effects of tibolone in older postmenopausal women. New Eng J Med 359(7):697\u2013708","journal-title":"New Eng J Med"},{"issue":"19","key":"1263_CR118","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY et al (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344(19):1434\u20131441","journal-title":"N Engl J Med"},{"key":"1263_CR119","doi-asserted-by":"publisher","unstructured":"Pepe J, Body J-J, Hadji P, McCloskey E, Meier C, Obermayer-Pietsch B, et al (2020) Osteoporosis in premenopausal women: a clinical narrative review by the ECTS and the IOF. J Clin Endocrinol Metab [Internet]. 105(8):2487\u2013506. Available from: https:\/\/doi.org\/10.1210\/clinem\/dgaa306","DOI":"10.1210\/clinem\/dgaa306"},{"issue":"8","key":"1263_CR120","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","volume":"69","author":"L Buckley","year":"2017","unstructured":"Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE et al (2017) 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol (Hoboken, NJ) 69(8):1521\u20131537","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"issue":"2","key":"1263_CR121","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jbmr.4188","volume":"36","author":"A Gilsenan","year":"2021","unstructured":"Gilsenan A, Midkiff K, Harris D, Kellier-Steele N, McSorley D, Andrews EB (2021) Teriparatide did not increase adult osteosarcoma incidence in a 15-year US postmarketing surveillance study. J Bone Miner Res 36(2):244\u2013251","journal-title":"J Bone Miner Res"},{"key":"1263_CR122","doi-asserted-by":"crossref","unstructured":"Licata AA (2005) Osteoporosis, teriparatide, and dosing of calcium and vitamin D. Vol. 352, The New England journal of medicine. United States; p. 1930\u20131.","DOI":"10.1056\/NEJM200505053521822"},{"issue":"5","key":"1263_CR123","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/jbmr.3384","volume":"33","author":"P Geusens","year":"2018","unstructured":"Geusens P, Marin F, Kendler DL, Russo LA, Zerbini CA, Minisola S et al (2018) Effects of teriparatide compared with risedronate on the risk of fractures in subgroups of postmenopausal women with severe osteoporosis: the VERO trial. J Bone Miner Res 33(5):783\u2013794","journal-title":"J Bone Miner Res"},{"key":"1263_CR124","doi-asserted-by":"crossref","unstructured":"Cosman F, Nieves JW, Dempster DW (2017) Treatment sequence matters: anabolic and antiresorptive therapy for osteoporosis. J Bone Miner Res 32(2):198\u2013202. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27925287. Accessed October 2021","DOI":"10.1002\/jbmr.3051"},{"key":"1263_CR125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coph.2016.02.012","volume":"28","author":"T Harslof","year":"2016","unstructured":"Harslof T, Langdahl BL (2016) New horizons in osteoporosis therapies. Curr Opin Pharmacol 28:38\u201342","journal-title":"Curr Opin Pharmacol"},{"issue":"2","key":"1263_CR126","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s11914-017-0353-4","volume":"15","author":"BZ Leder","year":"2017","unstructured":"Leder BZ (2017) Parathyroid hormone and parathyroid hormone-related protein analogs in osteoporosis therapy. Curr Osteoporos Rep 15(2):110\u2013119","journal-title":"Curr Osteoporos Rep"},{"issue":"8","key":"1263_CR127","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1210\/jc.2018-00163","volume":"103","author":"HG Bone","year":"2018","unstructured":"Bone HG, Cosman F, Miller PD, Williams GC, Hattersley G, Hu MY et al (2018) ACTIVExtend: 24 months of alendronate after 18 months of abaloparatide or placebo for postmenopausal osteoporosis. J Clin Endocrinol Metab 103(8):2949\u20132957","journal-title":"J Clin Endocrinol Metab"},{"issue":"16","key":"1263_CR128","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","volume":"375","author":"F Cosman","year":"2016","unstructured":"Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S et al (2016) Romosozumab treatment in postmenopausal women with osteoporosis. N Engl J Med 375(16):1532\u20131543","journal-title":"N Engl J Med"},{"key":"1263_CR129","unstructured":"U.S. Food and Drug Administration (2019) Romosozumab FDA label [Internet]. 2019. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/761062s000lbl.pdf. Accessed October 2021"},{"issue":"5","key":"1263_CR130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","volume":"370","author":"M McClung","year":"2014","unstructured":"McClung M, Grauer A, Boonen S, Bolognese M, Brown J, Diez-Perez A et al (2014) Romosozumab in postmenopausal women with low bone mineral density. New Eng J Med 370(5):412\u2013420","journal-title":"New Eng J Med"},{"key":"1263_CR131","doi-asserted-by":"crossref","unstructured":"Confavreux CB, Paccou J, David C, Mehsen N, Leboime A, Thomas T (2010) Defining treatment failure in severe osteoporosis. JT Bone Spine 77(Suppl 2):S128\u201332. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21211750. Accessed October 2021","DOI":"10.1016\/S1297-319X(10)70008-7"},{"key":"1263_CR132","doi-asserted-by":"crossref","unstructured":"Fleet JC, Schoch RD (2010) Molecular mechanisms for regulation of intestinal calcium absorption by vitamin D and other factors. Crit Rev Clin Lab Sci 47(4):181\u201395. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/21182397. Accessed October 2021","DOI":"10.3109\/10408363.2010.536429"},{"key":"1263_CR133","doi-asserted-by":"crossref","unstructured":"Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, et al (2017) UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 12(1)","DOI":"10.1007\/s11657-017-0324-5"},{"issue":"1","key":"1263_CR134","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00198-012-2074-y","volume":"24","author":"J Kanis","year":"2013","unstructured":"Kanis J, McCloskey E, Johansson H, Cooper C, Rizzoli R, Reginster J (2013) European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int 24(1):23\u201357","journal-title":"Osteoporos Int"},{"key":"1263_CR135","doi-asserted-by":"crossref","unstructured":"Pilz S, Zittermann A, Trummer C, Theiler-Schwetz V, Lerchbaum E, Keppel MH, et al (2019) Vitamin D testing and treatment: a narrative review of current evidence. Endocr Connect. R27\u201343","DOI":"10.1530\/EC-18-0432"},{"key":"1263_CR136","first-page":"105","volume":"12","author":"J Narvaez","year":"2020","unstructured":"Narvaez J, Maldonado G, Guerrero R, Messina OD, Rios C (2020) Vitamin D megadose: definition, efficacy in bone metabolism, risk of falls and fractures. Open access Rheumatol Res Rev 12:105\u2013115","journal-title":"Open access Rheumatol Res Rev"},{"issue":"2","key":"1263_CR137","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamainternmed.2015.7148","volume":"176","author":"HA Bischoff-Ferrari","year":"2016","unstructured":"Bischoff-Ferrari HA, Dawson-Hughes B, John Orav E, Staehelin HB, Meyer OW, Theiler R et al (2016) Monthly high-dose Vitamin D treatment for the prevention of functional decline a randomized clinical trial. JAMA Intern Med 176(2):175\u2013183","journal-title":"JAMA Intern Med"},{"issue":"7","key":"1263_CR138","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","volume":"96","author":"MF Holick","year":"2011","unstructured":"Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911\u20131930","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"1263_CR139","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","volume":"303","author":"KM Sanders","year":"2010","unstructured":"Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA - J Am Med Assoc 303(18):1815\u20131822","journal-title":"JAMA - J Am Med Assoc"},{"issue":"1","key":"1263_CR140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-017-1921-6","volume":"19","author":"EY Liao","year":"2018","unstructured":"Liao EY, Zhang ZL, Xia WB, Lin H, Cheng Q, Wang L et al (2018) Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium\/vitamin D 3 combination in Chinese women with postmenopausal osteoporosis: a post hoc efficacy analysis and safety reappraisal. BMC Musculoskelet Disord 19(1):1\u20138","journal-title":"BMC Musculoskelet Disord"},{"issue":"9","key":"1263_CR141","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199808273390905","volume":"339","author":"JP Bilezikian","year":"1998","unstructured":"Bilezikian JP, Morishima A, Bell J, Grumbach MM (1998) Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339(9):599\u2013603","journal-title":"N Engl J Med"},{"issue":"2","key":"1263_CR142","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1056\/NEJM199707103370204","volume":"337","author":"C Carani","year":"1997","unstructured":"Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J et al (1997) Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337(2):91\u201395","journal-title":"N Engl J Med"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-023-01263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-023-01263-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-023-01263-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T13:33:48Z","timestamp":1704375228000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-023-01263-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1263"],"URL":"https:\/\/doi.org\/10.1007\/s11657-023-01263-5","relation":{},"ISSN":["1862-3514"],"issn-type":[{"type":"electronic","value":"1862-3514"}],"subject":[],"published":{"date-parts":[[2023,6,15]]},"assertion":[{"value":"14 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"81"}}